MLchartDataset catalogue

miridesap

Term · Oncology and biomedicine · MLC-T-ONC-015199

A small molecule compound that depletes serum amyloid P component (SAP), with potential anti-amyloid activity. Upon injection, miridesap binds to circulating SAP, forming complexes that are rapidly cleared in the liver. SAP bound to amyloid deposits is in equilibrium with plasma SAP, and depletion of the latter should lead to the eventual removal of SAP from amyloid deposits as well. SAP is a universal component of amyloid deposits and contributes to the pathogenesis of amyloidosis.

Table 1. Record
IdentifierMLC-T-ONC-015199
FieldOncology and biomedicine
AbbreviationCPHPC
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015199",
  "term": "miridesap",
  "field": "Oncology and biomedicine",
  "definition": "A small molecule compound that depletes serum amyloid P component (SAP), with potential anti-amyloid activity. Upon injection, miridesap binds to circulating SAP, forming complexes that are rapidly cleared in the liver. SAP bound to amyloid deposits is in equilibrium with plasma SAP, and depletion of the latter should lead to the eventual removal of SAP from amyloid deposits as well. SAP is a universal component of amyloid deposits and contributes to the pathogenesis of amyloidosis.",
  "abbreviation": "CPHPC",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/miridesap/"
}

Record 11,090 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.